Quantitative brain 18 F‐FDG PET / CT analysis in seronegative autoimmune encephalitis
Annals of Clinical and Translational Neurology · 2024-05 · 11 (5) · 1211-1223
DOI: 10.1002/acn3.52035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 07.03.2024. Verfasst von Samantha N Roman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Encephalitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Brain 18 F‐FDG PET/CT is a useful diagnostic in evaluating patients with suspected autoimmune encephalitis (AE). Specific patterns of brain dysmetabolism have been reported in anti‐NMDAR and anti‐LGI1 AE, and the degree of dysmetabolism may correlate with clinical functional status. 18 FDG‐PET/CT abnormalities have not yet been described in seronegative AE.
Methods
We conducted a cross‐sectional analysis of brain 18 FDG‐PET/CT data in people with seronegative AE treated at the Johns Hopkins Hospital. Utilizing NeuroQ™ software, the Z‐scores of 47 brain regions were calculated relative to healthy controls, then visually and statistically compared for probable and possible AE per clinical consensus diagnostic criteria to previous data from anti‐NMDAR and anti‐LGI1 cohorts.
Results
Eight probable seronegative AE and nine possible seronegative AE were identified. The group only differed in frequency of abnormal brain MRI, which was seen in all of the probable seronegative AE patients. Both seronegative groups had similar overall patterns of brain dysmetabolism. A common pattern of frontal lobe hypometabolism and medial temporal lobe hypermetabolism was observed in patients with probable and possible seronegative AE, as well as anti‐NMDAR and anti‐LGI1 AE as part of their respective characteristic patterns of dysmetabolism. Four patients had multiple brain 18 FDG‐PET/CT scans, with changes in number and severity of abnormal brain regions mirroring clinical status.
Conclusions
A 18 FDG‐PET/CT pattern of frontal lobe hypometabolism and medial temporal lobe hypermetabolism could represent a common potential biomarker of AE, which along with additional clinical data may facilitate earlier diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Samantha N Roman, Moe S Sadaghiani, John C Probasco
Zitieren
APA
Roman, S. N., Sadaghiani, M. S., Diaz-Arias, L. A., Le Marechal, M., Venkatesan, A., Solnes, L. B., & Probasco, J. C. (2024). Quantitative brain 18 F‐FDG PET / CT analysis in seronegative autoimmune encephalitis. Annals of Clinical and Translational Neurology, 11(5), 1211-1223. https://doi.org/10.1002/acn3.52035
Vancouver
Roman SN, Sadaghiani MS, Diaz-Arias LA, Le Marechal M, Venkatesan A, Solnes LB, et al. Quantitative brain 18 F‐FDG PET / CT analysis in seronegative autoimmune encephalitis. Annals of Clinical and Translational Neurology. 2024;11(5):1211-1223. doi:10.1002/acn3.52035
BibTeX
@article{Roman2024,
author = {Roman, Samantha N and Sadaghiani, Moe S and Diaz-Arias, Luisa A and Le Marechal, Marion and Venkatesan, Arun and Solnes, Lilja B and Probasco, John C},
title = {Quantitative brain 18 F‐FDG PET / CT analysis in seronegative autoimmune encephalitis},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
volume = {11},
number = {5},
pages = {1211--1223},
doi = {10.1002/acn3.52035}
}
EUVIMED